Related Experiment Video
Updated: May 15, 2025
07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
162
Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis
Yuanyuan Li1, Yiheng Cheng1, Yuchen Cai1
1Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Biomedicines
|April 29, 2025
Summary
Psoriasis treatments are evolving beyond traditional drugs. Novel nanocarrier systems and cell-based therapies show promise for improved psoriasis management and drug delivery.
Area of Science:
- Dermatology and immunology, focusing on immune-related skin disorders.
Background:
- Psoriasis is a chronic immune-mediated skin disease characterized by keratinocyte hyperproliferation and inflammation.
- Current treatments include small-molecule drugs and biological therapies, each with limitations in efficacy, side effects, cost, or administration.
- Despite advancements, existing psoriasis therapies do not fully meet clinical needs, necessitating innovative solutions.
Purpose of the Study:
- To review the current landscape of psoriasis therapeutics.
- To explore novel drug delivery systems, including nanocarriers, for enhanced psoriasis treatment.
- To discuss emerging cell-based therapies for managing psoriasis.
Main Methods:
- Comprehensive review of existing literature on psoriasis treatments.
- Analysis of current small-molecule and biologic drug classes.
- Evaluation of emerging therapeutic strategies like nanocarriers and cell-based therapies.
Main Results:
- Biological therapies offer targeted action but face challenges with cost and administration.
- Spesolimab, targeting IL-36R, shows significant efficacy in reducing general pustular psoriasis flares.
- Advanced delivery systems and cell-based therapies are under investigation to overcome current treatment limitations.
Conclusions:
- The development of advanced drug delivery systems is crucial for optimizing psoriasis treatment.
- Nanocarriers and cell-based therapies represent promising future directions for psoriasis management.
- Further research is needed to fully realize the potential of novel therapeutic strategies for psoriasis.
Related Concept Videos
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:30siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K